Some Israeli companies have a knack for going public and getting in on the ground floor of important markets. Teva Pharmaceuticals (TEVA) jumped into the generic-drug space in 1982. Check Point (CHKP) went public as a security software play in 1996. Jerusalem-based Mobileye (MBLY) went public in August in hot pursuit of a rapidly developing automotive safety market. In 1989, few auto buyers had ever heard of antilock brakes.